Subscribe

DexCom, Inc. (DXCM)

USD76.35 +1.39 (+1.85%)
US NASDAQ S&P 500 NASDAQ 100 Healthcare Medical - Devices
Address 6340 Sequence Drive 92121
San Diego, CA, US
CEO Jacob Steven Leach
Website dexcom.com
IPO 2005-04-14
CIK 1093557 ISIN US2521311074

Explore sections of this company profile

Description

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.

News Sentiment (7d)
72 Positive

3 articles

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Index membership

IndexAddedRemovedStatus
S&P 500 2020-05-11 — Active
NASDAQ 100 2020-04-20 — Active
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD76.35 +1.39 (+1.85%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
6M
Beta
1.45
Float Shares
383.95M
Free Float %
99.5%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+3.05% +0.38% -3.14% -12.68% +2.38% -7.88% -27.31% -48.88% -24.51% +303.30% +1,979.59%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (52 ratings, all time) Buy
Price Targets & DCF
Current price
76.35
Low 67.00 -12.2%
Consensus 80.88 +5.9%
Median 78.50 +2.8%
High 100.00 +31.0%
DCF (Unlevered) 36.47 -52.2%
DCF (Levered) 77.89 +2.0%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 89% Bullish
Rating 2026-05 Change
Strong Buy 4 0
Buy 20 0
Hold 2 0
Sell 0 0
Strong Sell 1 0
Price Target Summary
Period # Analysts Avg Target
Last Month 6
80.00
+4.8%
Last Quarter 10
82.40
+7.9%
Last Year 26
83.50
+9.4%
All Time 67
81.99
+7.4%
Quality scores
Altman Z-Score
6.03
Safe zone
Piotroski F-Score
8 / 9
Strong
MOAT Score
6 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Devices: +11.2%
    +15.6% ★ Q1'26: +15.0% (vs Q1'25)
  • ✓
    EPS growth Medical - Devices: +28.5%
    +47.2% ★ Q1'26: +88.9% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Devices: +30.9%
    +16.0% Q1'26: +37.7% (vs Q1'25)
  • ✗
    EBIT margin Medical - Devices: +6.2%
    +19.6% ★ Q1'26: +21.4% (vs Q1'25)
  • ✓
    ROIC Medical - Devices: +3.3%
    +32.8% ★ Q1'26: +39.2% (vs Q1'25)
  • ✓
    Share dilution Medical - Devices: 0.0%
    -1.7% ★ Q1'26: -3.4% (vs Q1'25)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×
    1.19× ★ Q1'26: 1.07× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.40) × ERP
WACC = 95% × Ke + 5% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 36.14 Current price: 76.35
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2011
actual 		Dec 2012
actual 		Dec 2013
actual 		Dec 2014
actual 		Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
20 Rev. Ana.
14 EPS Ana. 		Dec 2027
20 Rev. Ana.
14 EPS Ana. 		Dec 2028
19 Rev. Ana.
6 EPS Ana. 		Dec 2029
10 Rev. Ana.
4 EPS Ana. 		Dec 2030
16 Rev. Ana.
2 EPS Ana.
Revenue
76.27M
est: 88.78M (-14.1%)
99.90M
est: 105.19M (-5.0%)
160.00M
est: 232.55M (-31.2%)
259.20M
est: 283.71M (-8.6%)
402.00M
est: 395.17M (+1.7%)
573.30M
est: 570.26M (+0.5%)
718.50M
est: 712.66M (+0.8%)
1.03B
est: 1.00B (+3.0%)
1.48B
est: 1.46B (+1.4%)
1.93B
est: 1.91B (+0.7%)
2.45B
est: 2.45B (0.0%)
2.91B
est: 2.91B (+0.2%)
3.62B
est: 3.93B (-7.9%)
4.03B
est: 4.03B (+0.1%)
4.66B
est: 4.65B (+0.2%)
5.23B
5.21B – 5.25B
+12.4% YoY
5.85B
5.77B – 5.92B
+11.8% YoY
6.54B
6.54B – 6.54B
+11.9% YoY
7.42B
7.33B – 7.52B
+13.5% YoY
8.49B
8.39B – 8.61B
+14.4% YoY
EBITDA
-40.98M
est: -37.79M (-8.4%)
-49.00M
est: -46.40M (-5.6%)
-21.90M
est: -25.16M (+13.0%)
-13.10M
est: -2.88M (-354.4%)
-46.30M
est: 81.53M (-156.8%)
-49.20M
est: -44.29M (-11.1%)
-19.70M
est: -12.73M (-54.8%)
-74.70M
est: 42.95M (-273.9%)
213.20M
est: 243.71M (-12.5%)
376.80M
est: 335.47M (+12.3%)
377.50M
est: 305.44M (+23.6%)
565.30M
est: 398.67M (+41.8%)
916.70M
est: 1.38B (-33.6%)
945.70M
est: 1.42B (-33.2%)
1.16B
est: 1.63B (-28.8%)
1.84B
1.83B – 1.84B
+12.4% YoY
2.05B
2.02B – 2.08B
+11.8% YoY
2.30B
2.29B – 2.30B
+11.9% YoY
2.61B
2.57B – 2.64B
+13.5% YoY
2.98B
2.95B – 3.02B
+14.4% YoY
EBIT
-44.74M
est: -41.41M (-8.0%)
-55.60M
est: -53.07M (-4.8%)
-28.90M
est: -33.67M (+14.2%)
-21.50M
est: -13.64M (-57.7%)
-57.10M
est: 62.93M (-190.7%)
-64.20M
est: -57.85M (-11.0%)
-35.80M
est: -42.83M (+16.4%)
-103.80M
est: -185.36M (+44.0%)
164.50M
est: 93.60M (+75.7%)
309.70M
est: 265.44M (+16.7%)
275.60M
est: 199.14M (+38.4%)
409.40M
est: 222.39M (+84.1%)
730.70M
est: 1.13B (-35.5%)
728.00M
est: 1.16B (-37.3%)
911.80M
est: 1.34B (-31.9%)
1.51B
1.50B – 1.51B
+12.4% YoY
1.68B
1.66B – 1.70B
+11.8% YoY
1.88B
1.88B – 1.88B
+11.9% YoY
2.14B
2.11B – 2.17B
+13.5% YoY
2.44B
2.42B – 2.48B
+14.4% YoY
Net Income
-44.75M
est: -41.32M (-8.3%)
-54.50M
est: -52.05M (-4.7%)
-29.80M
est: -34.77M (+14.3%)
-22.40M
est: -14.86M (-50.8%)
-57.60M
est: -28.81M (-99.9%)
-65.60M
est: -59.59M (-10.1%)
-50.20M
est: -54.63M (+8.1%)
-127.10M
est: -41.91M (-203.3%)
101.10M
est: 5.17M (+1,856.0%)
493.60M
est: 469.89M (+5.0%)
216.90M
est: 108.96M (+99.1%)
341.20M
est: 212.70M (+60.4%)
541.50M
est: 694.21M (-22.0%)
576.20M
est: 668.67M (-13.8%)
836.30M
est: 831.38M (+0.6%)
1.03B
1.00B – 1.07B
+24.3% YoY
1.17B
1.14B – 1.35B
+13.5% YoY
1.41B
1.18B – 1.70B
+20.5% YoY
1.76B
1.73B – 1.79B
+24.2% YoY
2.08B
2.05B – 2.12B
+18.7% YoY
SGA
49.94M
est: 46.84M (+6.6%)
62.80M
est: 62.68M (+0.2%)
84.20M
est: 102.96M (-18.2%)
128.40M
est: 164.50M (-21.9%)
198.00M
est: 129.85M (+52.5%)
286.20M
est: 268.02M (+6.8%)
349.20M
est: 450.70M (-22.5%)
432.80M
est: 732.87M (-40.9%)
515.70M
est: 1.15B (-55.3%)
620.70M
est: 575.56M (+7.8%)
810.50M
est: 733.21M (+10.5%)
1.01B
est: 1.03B (-1.9%)
1.19B
est: 1.26B (-5.9%)
1.29B
est: 1.29B (-0.3%)
1.29B
est: 1.49B (-13.3%)
1.67B
1.67B – 1.68B
+12.4% YoY
1.87B
1.85B – 1.89B
+11.8% YoY
2.09B
2.09B – 2.09B
+11.9% YoY
2.38B
2.35B – 2.41B
+13.5% YoY
2.72B
2.68B – 2.75B
+14.4% YoY
EPS
-0.17
est: -0.04 (-325.0%)
-0.20
est: -0.05 (-344.4%)
-0.10
est: -0.04 (-185.7%)
-0.07
est: -0.02 (-396.7%)
-0.18
est: -0.07 (-157.9%)
-0.20
est: -0.20 (-1.5%)
-0.15
est: -0.15 (+2.0%)
-0.36
est: -0.02 (-1,512.4%)
0.28
est: 0.36 (-21.7%)
1.31
est: 0.76 (+71.8%)
0.56
est: 0.71 (-20.7%)
0.88
est: 0.80 (+10.5%)
1.44
est: 1.71 (-15.8%)
1.46
est: 1.67 (-12.5%)
2.14
est: 2.06 (+3.9%)
2.58
2.47 – 2.63
+25.2% YoY
3.06
2.82 – 3.34
+18.5% YoY
3.65
2.92 – 4.19
+19.3% YoY
4.33
4.26 – 4.41
+18.8% YoY
5.14
5.06 – 5.23
+18.7% YoY
Recent Grade Changes (3M)
Date Firm Previous New Grade Action
2026-05-04 Citigroup Buy Buy Maintain
2026-05-01 TD Cowen Buy Buy Maintain
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-11 B+ 3/5 4/5 5/5 5/5 2/5 2/5 1/5
2026-05-08 B+ 3/5 4/5 5/5 5/5 2/5 2/5 1/5
2026-05-07 B+ 3/5 4/5 5/5 5/5 2/5 2/5 1/5
2026-05-06 B+ 3/5 4/5 5/5 5/5 2/5 2/5 1/5
2026-05-05 B+ 3/5 4/5 5/5 5/5 2/5 2/5 1/5
2026-05-04 B+ 3/5 4/5 5/5 5/5 2/5 2/5 1/5
2026-05-01 B+ 3/5 4/5 5/5 5/5 1/5 2/5 1/5
2026-04-30 B+ 3/5 4/5 5/5 5/5 1/5 2/5 1/5
2026-04-29 B+ 3/5 4/5 5/5 5/5 1/5 2/5 1/5
2026-04-28 B+ 3/5 4/5 5/5 5/5 1/5 2/5 1/5
2026-04-27 B+ 3/5 4/5 5/5 5/5 1/5 2/5 1/5
2026-04-24 B+ 3/5 4/5 5/5 5/5 1/5 2/5 1/5
2026-04-23 B+ 3/5 4/5 5/5 5/5 1/5 2/5 1/5
2026-04-22 B+ 3/5 4/5 5/5 5/5 1/5 2/5 1/5
2026-04-21 B+ 3/5 4/5 5/5 5/5 1/5 2/5 1/5
2026-04-20 B+ 3/5 4/5 5/5 5/5 1/5 2/5 1/5
2026-04-17 B+ 3/5 4/5 5/5 5/5 1/5 2/5 1/5
2026-04-16 B+ 3/5 4/5 5/5 5/5 1/5 2/5 1/5
2026-04-15 B+ 3/5 4/5 5/5 5/5 1/5 2/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
1.66B
OE per share TTM
4.13
Owner's Yield
7.26%
Maintenance CapEx ratio
11.51%
Maint CapEx / Avg PPE
34.4%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
264
Total invested
1.11B
Insider transactions (90d)
0
Beneficial owners (>5%)
30
Beneficial owners (>5%)
# Reporting person ⇅ Amount owned ⇅ % of class ⇅ Sole voting ⇅ Shared voting ⇅ Sole dispositive ⇅ Shared dispositive ⇅ Type Citizenship Filing date ⇅ SEC filing
1 (1) BlackRock, Inc. 40.45M 10.40% 37.55M — 40.45M — HC Delaware 2024-12-06 ↗
2 Brown Advisory Incorporated ("BA Inc.") 40.27M 4.76% 3.24M — — — HC BA, Inc. is a Maryland Corporation 2017-02-10 ↗
3 The Vanguard Group - 23-1945930 10.41M 10.74% — 164.6K 10.01M 401.6K IA Pennsylvania 2022-02-09 ↗
4 Wellington Management Company LLP 8.42M 9.69% — 4.30M — — IA Massachusetts 2017-12-11 ↗
5 Artisan Investments GP LLC 6.81M 8.10% — — 252.13M 6.81M HC Delaware 2017-02-03 ↗
6 Artisan Partners Asset Management Inc. 6.81M 8.10% — — 252.13M 6.81M HC Delaware 2017-02-03 ↗
7 Artisan Partners Holdings LP 6.81M 8.10% — — 252.13M 6.81M HC Delaware 2017-02-03 ↗
8 Artisan Partners Limited Partnership 6.81M 8.10% — — 252.13M 6.81M IA Delaware 2017-02-03 ↗
9 Baillie Gifford & Co (Scottish partnership) 5.45M 11.00% — — — — IA SCOTLAND UK 2021-01-14 ↗
10 JPMORGAN CHASE & CO13-2624428 5.02M 5.60% 4.81M — 5.02M 1.1K HC Delaware 2019-01-10 ↗
11 Morgan Stanley 4.77M 5.30% — — — 13.00 HC, CO Delaware. 2019-02-12 ↗
12 Morgan Stanley Investment Management Inc. 4.77M 5.30% — — — 13.00 IA, CO Delaware. 2019-02-12 ↗
13 The TCW Group, Inc., on behalf of the TCW Business Unit 4.48M 6.60% — — — — HC, CO Nevada 2012-02-09 ↗
14 04-2683227 4.15M 5.78% — 3.34M — — IA Massachusetts 2014-02-14 ↗
15 Gilder, Gagnon, Howe & Co. LLC 4.04M 5.63% 40.2K — 40.2K — BD New York 2014-02-12 ↗
16 Federated Investors, Inc. 3.96M 5.18% 3.96M — 3.96M — HC Citizenship or place of Organization 2015-02-11 ↗
17 J. Christopher Donahue 3.96M 5.18% — 3.96M — 3.96M IN Citizenship or place of Organization 2015-02-11 ↗
18 John F. Donahue 3.96M 5.18% — 3.96M — 3.96M IN Citizenship or place of Organization 2015-02-11 ↗
19 Rhodora J. Donahue 3.96M 5.18% — 3.96M — 3.96M IN Citizenship or place of Organization 2015-02-11 ↗
20 Voting Shares Irrevocable Trust 3.96M 5.18% 3.96M — 3.96M — OO Citizenship or place of Organization 2015-02-11 ↗
21 Brown Advisory LLC ("BA,LLC") 3.95M 4.66% 3.16M 4.3K — — IA BA LLC is a Maryland Limited Liability Company 2017-02-10 ↗
22 Abigail P. Johnson 3.86M 5.04% — — 3.86M — IN United States of America 2015-02-13 ↗
23 Edward C. Johnson 3d 3.86M 5.04% — — 3.86M — IN United States of America 2015-02-13 ↗
24 FMR LLC 3.86M 5.04% 200.8K — 3.86M — HC United States of America 2015-02-13 ↗
25 Wellington Group Holdings LLP 3.81M 4.31% — 1.83M — — HC Massachusetts 2018-08-10 ↗
26 Wellington Investment Advisors Holdings LLP 3.81M 4.31% — 1.83M — — HC Massachusetts 2018-08-10 ↗
27 Wellington Management Group LLP 3.81M 4.31% — 1.83M — — HC Massachusetts 2018-08-10 ↗
28 2 2.50M 5.60% 2.50M — 2.50M — CO Delaware, U.S.A. 2018-02-23 ↗
29 52-0556948 2.14M 2.20% 564.9K — 2.14M — IA Maryland 2021-02-16 ↗
30 Brown Investment Advisory & Trust Company ("BIATC") 81.9K 0.10% 81.9K — — — BK BIATC is a Maryland Company 2017-02-10 ↗

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
264
-715 vs prev Q
New positions
34
Closed positions
691
Increased
128
Reduced
95
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
# Investor ⇅ Shares / Δ ⇅ Mkt value / Δ ⇅ Own% / Δ ⇅ Weight% / Δ ⇅ Avg px / Perf. ⇅ Hold / Status ⇅
1 VANGUARD GROUP INC 49.07M -381.7K (-0.8%) 3.26B -70.8M (-2.1%) 12.69% +0.077 pp 0.05% -0.003 pp USD42.20 +57.3% 83 qtrs —
2 BLACKROCK, INC. 39.85M +1.0M (+2.6%) 2.64B +32.4M (+1.2%) 10.30% +0.404 pp 0.04% -0.001 pp USD68.23 -2.7% 6 qtrs —
3 STATE STREET CORP 18.09M +1.2M (+7.3%) 1.20B +66.7M (+5.9%) 4.68% +0.380 pp 0.04% +0.001 pp USD66.57 -0.3% 51 qtrs —
4 BAILLIE GIFFORD & CO 15.55M -329.6K (-2.1%) 1.03B -36.5M (-3.4%) 3.98% -0.074 pp 0.86% +0.066 pp USD47.88 +38.6% 51 qtrs —
5 GEODE CAPITAL MANAGEMENT, LLC 11.01M +42.4K (+0.4%) 727.84M -7.1M (-1.0%) 2.85% +0.050 pp 0.04% -0.002 pp USD68.09 -2.5% 78 qtrs —
6 ALLIANCEBERNSTEIN L.P. 8.62M +8.2M (+1,955.4%) 572.38M +544.2M (+1,927.3%) 2.23% +2.123 pp 0.18% +0.172 pp USD66.76 -0.6% 61 qtrs —
7 UBS ASSET MANAGEMENT AMERICAS INC 8.00M +516.5K (+6.9%) 530.90M +27.4M (+5.4%) 2.05% +0.137 pp 0.11% +0.003 pp USD86.65 -23.4% 52 qtrs —
8 NORGES BANK 7.28M +7.3M (+100.0%) 483.36M +483.4M (+100.0%) 1.86% +1.862 pp 0.05% +0.052 pp USD66.37 +0.0% 1 qtrs NEW
9 JPMORGAN CHASE & CO 6.22M +2.6K (+0.0%) 412.58M -5.5M (-1.3%) 1.59% +0.005 pp 0.03% +0.001 pp USD75.65 -12.3% 51 qtrs —
10 JENNISON ASSOCIATES LLC 5.79M -4.3M (-42.6%) 384.28M -294.7M (-43.4%) 1.48% -1.093 pp 0.23% -0.165 pp USD70.48 -5.8% 53 qtrs —
11 INVESCO LTD. 5.32M +686.2K (+14.8%) 352.78M +41.3M (+13.3%) 1.37% +0.194 pp 0.05% +0.005 pp USD101.63 -34.7% 57 qtrs —
12 MORGAN STANLEY 5.07M +719.8K (+16.5%) 336.67M +43.8M (+14.9%) 1.31% +0.202 pp 0.02% +0.002 pp USD69.58 -4.6% 51 qtrs —
13 AMUNDI 4.92M -101.6K (-2.0%) 326.40M -6.7M (-2.0%) 1.27% -0.008 pp 0.09% -0.018 pp USD86.06 -22.9% 19 qtrs —
14 NUVEEN, LLC 4.63M -1.7M (-27.0%) 307.44M -119.4M (-28.0%) 1.20% -0.420 pp 0.08% -0.032 pp USD68.29 -2.8% 4 qtrs —
15 DEUTSCHE BANK AG\ 4.33M +1.5M (+51.9%) 287.33M +95.6M (+49.9%) 1.11% +0.380 pp 0.09% +0.029 pp USD68.42 -3.0% 50 qtrs —
16 D. E. SHAW & CO., INC. 3.94M +1.7M (+78.7%) 261.40M +113.1M (+76.3%) 1.02% +0.457 pp 0.14% +0.060 pp USD68.76 -3.5% 31 qtrs —
17 BANK OF AMERICA CORP /DE/ 3.81M -513.8K (-11.9%) 253.08M -38.1M (-13.1%) 0.99% -0.118 pp 0.02% -0.001 pp USD73.56 -9.8% 52 qtrs —
18 NORTHERN TRUST CORP 3.38M -345.1K (-9.3%) 224.09M -26.3M (-10.5%) 0.87% -0.076 pp 0.03% -0.004 pp USD58.55 +13.4% 51 qtrs —
19 CIBC PRIVATE WEALTH GROUP, LLC 3.13M +220.3K (+7.6%) 207.61M +11.9M (+6.1%) 0.80% +0.058 pp 0.35% +0.016 pp USD74.67 -11.1% 26 qtrs —
20 AQR CAPITAL MANAGEMENT LLC 3.10M +2.7M (+597.8%) 205.93M +176.2M (+591.7%) 0.80% +0.689 pp 0.11% +0.089 pp USD68.35 -2.9% 53 qtrs —
21 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 3.08M -103.8K (-3.3%) 204.37M -9.8M (-4.6%) 0.80% -0.016 pp 0.03% -0.002 pp USD72.70 -8.7% 64 qtrs —
22 WELLINGTON MANAGEMENT GROUP LLP 3.07M +3.0M (+3,777.3%) 203.99M +198.7M (+3,724.2%) 0.79% +0.775 pp 0.04% +0.035 pp USD66.45 -0.1% 68 qtrs —
23 FRANKLIN RESOURCES INC 2.68M +236.7K (+9.7%) 178.05M +13.5M (+8.2%) 0.69% +0.062 pp 0.04% +0.003 pp USD105.18 -36.9% 51 qtrs —
24 LEGAL & GENERAL GROUP PLC 2.61M -30.4K (-1.2%) 172.91M -4.4M (-2.5%) 0.67% -0.006 pp 0.04% -0.001 pp USD59.00 +12.5% 46 qtrs —
25 ROYAL BANK OF CANADA 2.54M -622.9K (-19.7%) 168.56M -44.3M (-20.8%) 0.66% -0.150 pp 0.03% -0.008 pp USD83.85 -20.8% 51 qtrs —
26 SQUAREPOINT OPS LLC 2.53M +1.4M (+132.7%) 167.75M +94.7M (+129.5%) 0.65% +0.377 pp 0.18% +0.105 pp USD66.93 -0.8% 34 qtrs —
27 RAYMOND JAMES FINANCIAL INC 2.45M -889.4K (-26.6%) 163.18M -61.7M (-27.4%) 0.63% -0.218 pp 0.05% -0.022 pp USD76.07 -12.8% 5 qtrs —
28 GOLDMAN SACHS GROUP INC 2.44M +307.5K (+14.4%) 161.80M +18.5M (+12.9%) 0.63% +0.087 pp 0.02% +0.002 pp USD97.47 -31.9% 73 qtrs —
29 DSM CAPITAL PARTNERS LLC 2.36M -178.4K (-7.0%) 156.31M -14.2M (-8.3%) 0.60% -0.044 pp 2.32% -0.114 pp USD75.56 -12.2% 9 qtrs —
30 NEUBERGER BERMAN GROUP LLC 2.34M +1.2M (+111.6%) 155.32M +80.9M (+108.7%) 0.61% +0.323 pp 0.12% +0.061 pp USD73.98 -10.3% 45 qtrs —
31 CASTLE HOOK PARTNERS LP 2.25M +1.6M (+272.5%) 149.40M +108.7M (+267.4%) 0.58% +0.428 pp 0.62% +0.415 pp USD66.62 -0.4% 2 qtrs —
32 AMERICAN CENTURY COMPANIES INC 2.24M -257.4K (-10.3%) 148.35M -19.4M (-11.6%) 0.58% -0.058 pp 0.07% -0.011 pp USD88.29 -24.8% 29 qtrs —
33 BANK OF NEW YORK MELLON CORP 2.20M -764.5K (-25.8%) 145.80M -53.5M (-26.8%) 0.56% -0.194 pp 0.03% -0.013 pp USD56.95 +16.5% 66 qtrs —
34 — 2.19M +— (+0.0%) 145.35M -2.0M (-1.4%) 0.57% +0.008 pp 1.07% -0.114 pp USD86.72 -23.5% 10 qtrs —
35 AMERIPRISE FINANCIAL INC 2.13M +1.3M (+163.2%) 141.25M +86.8M (+159.6%) 0.55% +0.344 pp 0.03% +0.019 pp USD76.66 -13.4% 51 qtrs —
36 JANUS HENDERSON GROUP PLC 2.00M -694.8K (-25.8%) 132.67M -48.6M (-26.8%) 0.52% -0.170 pp 0.06% -0.023 pp USD75.43 -12.0% 37 qtrs —
37 BLAIR WILLIAM & CO/IL 1.99M -120.5K (-5.7%) 132.00M -9.9M (-7.0%) 0.51% -0.024 pp 0.35% -0.024 pp USD32.50 +104.2% 51 qtrs —
38 UBS GROUP AG 1.92M -1.0M (-34.9%) 127.68M -71.2M (-35.8%) 0.50% -0.256 pp 0.02% -0.011 pp USD85.37 -22.3% 45 qtrs —
39 DIMENSIONAL FUND ADVISORS LP 1.87M +427.1K (+29.6%) 124.24M +27.1M (+27.8%) 0.48% +0.110 pp 0.03% +0.005 pp USD67.98 -2.4% 51 qtrs —
40 BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. 1.86M +1.5M (+491.8%) 123.71M +102.5M (+483.9%) 0.48% +0.402 pp 0.14% +0.087 pp USD71.42 -7.1% 39 qtrs —
41 LOS ANGELES CAPITAL MANAGEMENT LLC 1.81M +191.3K (+11.8%) 123.56M +14.5M (+13.3%) 0.46% +0.050 pp 0.42% +0.051 pp USD78.82 -15.8% 31 qtrs —
42 BNP PARIBAS ARBITRAGE, SNC 1.84M +231.4K (+14.4%) 122.03M +13.9M (+12.8%) 0.48% +0.066 pp 0.06% -0.003 pp USD85.22 -22.1% 51 qtrs —
43 DEKABANK DEUTSCHE GIROZENTRALE 850.3K +— (+0.0%) 117.80M +61.4M (+109.0%) 0.22% +0.003 pp 0.20% +0.109 pp USD101.63 -34.7% 29 qtrs —
44 SUSQUEHANNA INTERNATIONAL GROUP, LLP 1.61M +150.2K (+10.3%) 106.88M +8.6M (+8.8%) 0.42% +0.044 pp 0.01% +0.001 pp USD81.40 -18.5% 50 qtrs —
45 MILLENNIUM MANAGEMENT LLC 1.59M -1.8M (-53.7%) 105.52M -125.4M (-54.3%) 0.41% -0.464 pp 0.04% -0.054 pp USD68.03 -2.4% 60 qtrs —
46 ADAGE CAPITAL PARTNERS GP, L.L.C. 1.59M +1.4M (+666.9%) 105.37M +91.4M (+656.4%) 0.41% +0.358 pp 0.16% +0.137 pp USD69.12 -4.0% 24 qtrs —
47 PRICE T ROWE ASSOCIATES INC /MD/ 1.47M -429.1K (-22.6%) 97.49M -30.2M (-23.7%) 0.38% -0.104 pp 0.01% -0.003 pp USD93.51 -29.0% 60 qtrs —
48 RENAISSANCE TECHNOLOGIES LLC 1.44M +603.2K (+71.7%) 95.89M +39.3M (+69.3%) 0.37% +0.159 pp 0.15% +0.074 pp USD84.11 -21.1% 17 qtrs —
49 WESTFIELD CAPITAL MANAGEMENT CO LP 1.44M -872.5K (-37.7%) 95.55M -60.0M (-38.6%) 0.37% -0.222 pp 0.40% -0.255 pp USD90.58 -26.7% 30 qtrs —
50 CAPITAL WORLD INVESTORS 1.38M +— (+0.0%) 91.86M -1.3M (-1.4%) 0.35% +0.001 pp 0.01% 0.000 pp USD93.74 -29.2% 33 qtrs —
51 BARCLAYS PLC 1.34M +133.6K (+11.1%) 88.90M +8.1M (+10.0%) 0.35% +0.039 pp 0.02% +0.001 pp USD102.57 -35.3% 51 qtrs —
52 FMR LLC 1.30M -216.0K (-14.3%) 86.19M -15.7M (-15.4%) 0.34% -0.051 pp 0.00% -0.001 pp USD62.83 +5.6% 67 qtrs —
53 SOLEUS CAPITAL MANAGEMENT, L.P. 1.30M +1.3M (+100.0%) 86.09M +86.1M (+100.0%) 0.33% +0.332 pp 3.18% +3.176 pp USD66.37 +0.0% 1 qtrs NEW
54 VESTAL POINT CAPITAL, LP 1.28M +625.0K (+96.2%) 84.62M +40.9M (+93.5%) 0.33% +0.164 pp 2.88% +0.902 pp USD66.84 -0.7% 2 qtrs —
55 ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.27M +872.7K (+219.7%) 84.29M +57.6M (+215.3%) 0.33% +0.227 pp 0.05% +0.033 pp USD70.82 -6.3% 7 qtrs —
56 DNB ASSET MANAGEMENT AS 1.27M +170.8K (+15.6%) 84.25M +10.3M (+14.0%) 0.32% +0.044 pp 0.29% +0.018 pp USD71.52 -7.2% 25 qtrs —
57 ASSENAGON ASSET MANAGEMENT S.A. 1.23M +397.7K (+48.0%) 81.40M +25.6M (+46.0%) 0.31% +0.102 pp 0.11% +0.036 pp USD85.96 -22.8% 25 qtrs —
58 MACKENZIE FINANCIAL CORP 1.21M +106.3K (+9.6%) 81.11M +6.7M (+9.0%) 0.31% +0.031 pp 0.10% +0.006 pp USD78.51 -15.5% 60 qtrs —
59 FISHER FUNDS MANAGEMENT LTD 1.22M +1.8K (+0.1%) 81.10M -795.8K (-1.0%) 0.31% +0.001 pp 2.09% -0.069 pp USD75.42 -12.0% 5 qtrs —
60 POINT72 ASSET MANAGEMENT, L.P. 1.22M -1.0M (-45.5%) 80.81M -69.6M (-46.3%) 0.31% -0.255 pp 0.09% -0.161 pp USD67.29 -1.4% 5 qtrs —
61 MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. 1.17M +26.5K (+2.3%) 77.80M +909.1K (+1.2%) 0.30% +0.008 pp 0.05% -0.003 pp USD96.23 -31.0% 29 qtrs —
62 FEDERATED HERMES, INC. 1.15M -2.3M (-66.5%) 76.15M -154.0M (-66.9%) 0.29% -0.579 pp 0.13% -0.279 pp USD76.29 -13.0% 32 qtrs —
63 TWO SIGMA INVESTMENTS, LP 1.08M -418.2K (-27.9%) 71.87M -29.1M (-28.8%) 0.28% -0.103 pp 0.10% -0.049 pp USD72.44 -8.4% 18 qtrs —
64 SWISS NATIONAL BANK 1.07M -55.7K (-4.9%) 71.32M -4.7M (-6.2%) 0.27% -0.014 pp 0.04% -0.002 pp USD52.97 +25.3% 51 qtrs —
65 VICTORY CAPITAL MANAGEMENT INC 1.07M -14.0K (-1.3%) 70.83M -1.9M (-2.6%) 0.28% +0.000 pp 0.04% -0.003 pp USD66.97 -0.9% 45 qtrs —
66 FIRST TRUST ADVISORS LP 1.05M +34.6K (+3.4%) 69.63M +1.4M (+2.0%) 0.27% +0.013 pp 0.05% 0.000 pp USD92.62 -28.3% 42 qtrs —
67 STEPHENS INVESTMENT MANAGEMENT GROUP LLC 1.04M +181.7K (+21.1%) 69.21M +11.3M (+19.4%) 0.27% +0.047 pp 0.90% +0.150 pp USD45.37 +46.3% 44 qtrs —
68 ALPHABET INC. 1.04M +— (+0.0%) 68.82M -954.0K (-1.4%) 0.27% +0.001 pp 2.67% -0.229 pp USD115.64 -42.6% 29 qtrs —
69 BALYASNY ASSET MANAGEMENT L.P. 1.01M -616.5K (-37.8%) 67.36M -42.4M (-38.6%) 0.26% -0.154 pp 0.09% -0.054 pp USD71.34 -7.0% 9 qtrs —
70 RUSSELL INVESTMENTS GROUP, LTD. 1.01M +757.2K (+295.4%) 67.31M +50.1M (+291.0%) 0.26% +0.197 pp 0.07% +0.054 pp USD71.07 -6.6% 37 qtrs —
71 BANK OF NOVA SCOTIA 1.01M +505.3K (+100.1%) 67.05M +33.1M (+97.3%) 0.26% +0.133 pp 0.10% +0.039 pp USD71.42 -7.1% 23 qtrs —
72 PACER ADVISORS, INC. 982.8K +922.7K (+1,534.5%) 65.23M +61.2M (+1,512.1%) 0.25% +0.239 pp 0.17% +0.156 pp USD68.54 -3.2% 23 qtrs —
73 MAN GROUP PLC 962.6K +378.9K (+64.9%) 63.89M +24.6M (+62.7%) 0.25% +0.100 pp 0.11% +0.040 pp USD84.16 -21.1% 31 qtrs —
74 SUMITOMO MITSUI TRUST HOLDINGS, INC. 957.2K -16.0K (-1.6%) 63.53M -2.0M (-3.0%) 0.24% -0.004 pp 0.04% 0.000 pp USD51.14 +29.8% 29 qtrs —
75 WALLEYE CAPITAL LLC 924.7K +125.9K (+15.8%) 61.37M +7.6M (+14.2%) 0.24% +0.035 pp 0.19% -0.013 pp USD71.79 -7.5% 10 qtrs —
76 INTERMEDE INVESTMENT PARTNERS LTD 909.3K +909.3K (+100.0%) 60.35M +60.4M (+100.0%) 0.23% +0.233 pp 2.48% +2.480 pp USD66.37 +0.0% 1 qtrs NEW
77 HSBC HOLDINGS PLC 886.3K -372.6K (-29.6%) 58.91M -25.5M (-30.2%) 0.23% -0.092 pp 0.03% -0.017 pp USD95.86 -30.8% 44 qtrs —
78 CI INVESTMENTS INC. 885.7K +337.6K (+61.6%) 58.78M +21.9M (+59.4%) 0.23% +0.087 pp 0.26% +0.124 pp USD72.92 -9.0% 26 qtrs —
79 ALLIANZ ASSET MANAGEMENT GMBH 852.5K +749.2K (+725.1%) 56.58M +49.6M (+713.8%) 0.22% +0.192 pp 0.06% +0.050 pp USD69.46 -4.4% 47 qtrs —
80 BELLEVUE GROUP AG 847.4K +61.3K (+7.8%) 56.24M +3.3M (+6.3%) 0.22% +0.019 pp 1.07% -0.033 pp USD99.81 -33.5% 37 qtrs —
81 CITIGROUP INC 846.0K +190.8K (+29.1%) 56.15M +12.1M (+27.4%) 0.22% +0.052 pp 0.02% +0.005 pp USD83.34 -20.4% 56 qtrs —
82 WELLS FARGO & COMPANY/MN 811.9K -682.4K (-45.7%) 53.88M -46.7M (-46.4%) 0.21% -0.171 pp 0.01% -0.009 pp USD58.92 +12.6% 57 qtrs —
83 CANADA PENSION PLAN INVESTMENT BOARD 809.0K +149.2K (+22.6%) 53.69M +9.3M (+20.9%) 0.21% +0.041 pp 0.04% +0.005 pp USD92.03 -27.9% 32 qtrs —
84 MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 793.4K -4.8M (-85.9%) 52.66M -324.7M (-86.0%) 0.20% -1.228 pp 0.02% -0.100 pp USD87.97 -24.6% 9 qtrs —
85 ENVESTNET ASSET MANAGEMENT INC 776.5K -130.4K (-14.4%) 51.54M -9.5M (-15.5%) 0.20% -0.031 pp 0.02% -0.002 pp USD79.74 -16.8% 44 qtrs —
86 RHUMBLINE ADVISERS 775.8K -24.8K (-3.1%) 51.49M -2.4M (-4.4%) 0.20% -0.004 pp 0.04% -0.002 pp USD61.65 +7.7% 52 qtrs —
87 PICTET ASSET MANAGEMENT HOLDING SA 768.8K +1.6K (+0.2%) 51.02M -598.9K (-1.2%) 0.20% +0.001 pp 0.05% 0.000 pp USD90.41 -26.6% 10 qtrs —
88 TWO SIGMA ADVISERS, LP 748.1K +361.8K (+93.7%) 49.65M +23.7M (+91.0%) 0.19% +0.095 pp 0.10% +0.045 pp USD67.12 -1.1% 7 qtrs —
89 DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN 725.5K +53.5K (+8.0%) 48.15M +2.9M (+6.5%) 0.19% +0.016 pp 0.04% +0.002 pp USD109.57 -39.4% 22 qtrs —
90 ENSIGN PEAK ADVISORS, INC 699.1K -103.2K (-12.9%) 46.40M -7.6M (-14.1%) 0.18% -0.026 pp 0.08% -0.007 pp USD77.87 -14.8% 25 qtrs —
91 PROSHARE ADVISORS LLC 684.6K +190.5K (+38.5%) 45.44M +12.2M (+36.6%) 0.18% +0.049 pp 0.08% +0.011 pp USD91.93 -27.8% 31 qtrs —
92 CITADEL ADVISORS LLC 683.0K +269.9K (+65.3%) 45.33M +17.5M (+63.1%) 0.18% +0.071 pp 0.01% +0.003 pp USD74.35 -10.7% 38 qtrs —
93 ING GROEP NV 673.7K +168.8K (+33.4%) 44.71M +10.7M (+31.6%) 0.17% +0.044 pp 0.27% +0.086 pp USD68.70 -3.4% 7 qtrs —
94 PEREGRINE CAPITAL MANAGEMENT LLC 657.8K +126.9K (+23.9%) 43.66M +7.9M (+22.2%) 0.17% +0.033 pp 1.34% +0.263 pp USD68.99 -3.8% 38 qtrs —
95 J. STERN & CO. LLP 1.60M +1.5M (+2,114.8%) 1.60M -3.3M (-67.1%) 0.41% +0.396 pp 0.14% -0.232 pp USD66.81 -0.7% 9 qtrs —
Ownership breakdown by holder

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
1
Shares acquired
—
Shares disposed
1.7K
Cash buys
—
Cash sales
1.00
Net activity
-1,700
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-04-15 Brown Michael Jon Officer S-Sale D Common Stock 1,700 63.04 107.2K 111,204 D ↗
2026-03-16 Brown Michael Jon Officer S-Sale D Common Stock 1,700 64.85 110.2K 112,904 D ↗
2026-03-08 Sylvain Jereme M Officer A-Award A Common Stock 48,774 0.00 — 172,242 D ↗
2026-03-08 Stern Sadie Officer A-Award A Common Stock 39,019 0.00 — 148,709 D ↗
2026-03-08 SAYER KEVIN R Director / Officer A-Award A Common Stock 32,749 0.00 — 441,739 D ↗
2026-03-08 Leach Jacob Steven Director / Officer A-Award A Common Stock 104,516 0.00 — 441,567 D ↗
2026-03-08 Coleman Jon Officer A-Award A Common Stock 43,897 0.00 — 112,635 D ↗
2026-03-08 Brown Michael Jon Officer A-Award A Common Stock 39,019 0.00 — 137,929 D ↗
2026-02-26 Osterloh Albert Frederick IV Director — — — 0 0.00 — 0 — ↗
2026-02-12 Heller Bridgette P Director S-Sale D Common Stock 1,012 68.01 68.8K 26,019 D ↗
2026-01-29 Sylvain Jereme M Officer A-Award A Common Stock 7,123 0.00 — 125,859 D ↗
2026-01-29 Stern Sadie Officer A-Award A Common Stock 7,123 0.00 — 112,346 D ↗
2026-01-29 SAYER KEVIN R Director / Officer A-Award A Common Stock 71,218 0.00 — 443,247 D ↗
2026-01-29 Leach Jacob Steven Director / Officer A-Award A Common Stock 8,310 0.00 — 340,109 D ↗
2026-01-29 Brown Michael Jon Officer A-Award A Common Stock 7,123 0.00 — 101,308 D ↗
2025-11-14 Collins Richard Alexander Director S-Sale D Common Stock 2,906 59.05 171.6K 35,088 I ↗
2025-11-12 Heller Bridgette P Director S-Sale D Common Stock 1,012 58.07 58.8K 27,031 D ↗
2025-11-10 Leach Jacob Steven Officer P-Purchase A Common Stock 15,700 54.98 863.1K 329,197 D ↗
2025-11-10 Collins Richard Alexander Director S-Sale D Common Stock 3,948 55.17 217.8K 37,994 I ↗
2025-10-24 Ashley Euan A. Director A-Award A Common Stock 7,166 0.00 — 7,166 D ↗
2025-09-05 Malady Kyle Director S-Sale D Common Stock 667 80.86 53.9K 22,667 D ↗
2025-09-04 Stern Sadie Officer S-Sale D Common Stock 1,466 80.00 117.3K 105,223 D ↗
2025-09-02 Sylvain Jereme M Officer S-Sale D Common Stock 4,824 74.17 357.8K 118,657 D ↗
2025-08-15 FOLETTA MARK G Director S-Sale D Common Stock 2,555 81.02 207.0K 51,316 I ↗
2025-08-15 Brown Michael Jon Officer S-Sale D Common Stock 500 80.29 40.1K 94,102 D ↗
2025-07-28 Stern Sadie Officer S-Sale D Common Stock 1,466 88.99 130.5K 106,689 D ↗
2025-07-15 FOLETTA MARK G Director S-Sale D Common Stock 2,742 85.17 233.5K 53,879 I ↗
2025-07-15 Brown Michael Jon Officer S-Sale D Common Stock 500 86.03 43.0K 94,602 D ↗
2025-06-26 Stern Sadie Officer S-Sale D Common Stock 1,466 85.06 124.7K 108,155 D ↗
2025-06-16 FOLETTA MARK G Director S-Sale D Common Stock 2,750 83.13 228.6K 56,621 I ↗
2025-06-16 Brown Michael Jon Officer S-Sale D Common Stock 500 82.80 41.4K 95,102 D ↗
2025-06-16 AUGUSTINOS NICHOLAS Director S-Sale D Common Stock 3,672 82.80 304.0K 33,411 I ↗
2025-06-13 AUGUSTINOS NICHOLAS Director S-Sale D Common Stock 2,618 81.69 213.9K 37,083 I ↗
2025-05-27 Stern Sadie Officer S-Sale D Common Stock 6,184 85.11 526.3K 109,621 D ↗
2025-05-23 Brown Michael Jon Officer S-Sale D Common Stock 10,000 84.28 842.8K 95,602 D ↗
2025-05-22 Coleman Jon Officer A-Award A Common Stock 68,738 0.00 — 68,738 D ↗
2025-05-08 TOPOL ERIC Director G-Gift D Common Stock 2,618 0.00 — 0 D ↗
2025-05-08 Malady Kyle Director A-Award A Common Stock 5,192 0.00 — 23,334 D ↗
2025-05-08 Heller Bridgette P Director A-Award A Common Stock 5,046 0.00 — 28,043 D ↗
2025-05-08 GALA RENEE D Director A-Award A Common Stock 5,074 0.00 — 10,794 D ↗
2025-05-08 FOLETTA MARK G Director G-Gift A Common Stock 2,973 0.00 — 59,371 I ↗
2025-05-08 Driscoll Rimma Director A-Award A Common Stock 5,074 0.00 — 11,714 D ↗
2025-05-08 Dahut Karen M Director G-Gift D Common Stock 2,613 0.00 — 0 D ↗
2025-05-08 Collins Richard Alexander Director G-Gift D Common Stock 2,632 0.00 — 0 D ↗
2025-05-08 AUGUSTINOS NICHOLAS Director G-Gift D Common Stock 2,618 0.00 — 0 D ↗
2025-05-08 ALTMAN STEVEN R Director G-Gift D Common Stock 2,613 0.00 — 0 D ↗
2025-03-31 Coleman Jon Officer — — — 0 0.00 — 0 — ↗
2025-03-17 Heller Bridgette P Director S-Sale D Common Stock 352 70.33 24.8K 22,997 D ↗
2025-03-12 Sylvain Jereme M Officer S-Sale D Common Stock 12,001 70.38 844.6K 123,481 D ↗
2025-03-12 Stern Sadie Officer S-Sale D Common Stock 11,176 70.38 786.6K 115,805 D ↗
2025-03-12 SAYER KEVIN R Director / Officer S-Sale D Common Stock 32,498 70.38 2.29M 372,029 D ↗
2025-03-12 Leach Jacob Steven Officer S-Sale D Common Stock 14,076 70.38 990.7K 313,497 D ↗
2025-03-12 Brown Michael Jon Officer S-Sale D Common Stock 13,000 70.38 914.9K 105,602 D ↗
2025-03-10 Sylvain Jereme M Officer S-Sale D Common Stock 1,127 74.70 84.2K 135,482 D ↗
2025-03-08 Sylvain Jereme M Officer A-Award A Common Stock 22,798 0.00 — 142,482 D ↗
2025-03-08 Stern Sadie Officer A-Award A Common Stock 29,922 0.00 — 104,183 D ↗
2025-03-08 SAYER KEVIN R Director / Officer A-Award A Common Stock 85,490 0.00 — 404,527 D ↗
2025-03-08 Leach Jacob Steven Officer A-Award A Common Stock 35,906 0.00 — 304,775 D ↗
2025-03-08 Brown Michael Jon Officer A-Award A Common Stock 22,798 0.00 — 118,602 D ↗
2025-03-06 GALA RENEE D Director — — — 0 0.00 — 0 — ↗
2025-01-29 Sylvain Jereme M Officer S-Sale D Common Stock 2,090 86.91 181.7K 83,526 D ↗
2025-01-29 Stern Sadie Officer S-Sale D Common Stock 2,093 86.91 181.9K 74,261 D ↗
2025-01-29 SAYER KEVIN R Director / Officer S-Sale D Common Stock 33,359 86.91 2.90M 319,037 D ↗
2025-01-29 Leach Jacob Steven Officer S-Sale D Common Stock 2,634 86.91 228.9K 268,644 D ↗
2025-01-29 Dolan Matthew Vincent Officer S-Sale D Common Stock 1,183 86.91 102.8K 42,044 D ↗
2025-01-28 Sylvain Jereme M Officer A-Award A Common Stock 5,586 0.00 — 85,616 D ↗
2025-01-28 Stern Sadie Officer A-Award A Common Stock 5,586 0.00 — 76,354 D ↗
2025-01-28 SAYER KEVIN R Director / Officer A-Award A Common Stock 68,503 0.00 — 352,396 D ↗
2025-01-28 Leach Jacob Steven Officer A-Award A Common Stock 7,107 0.00 — 271,278 D ↗
2025-01-28 Dolan Matthew Vincent Officer A-Award A Common Stock 3,048 0.00 — 43,227 D ↗
2024-12-16 Sylvain Jereme M Officer S-Sale D Common Stock 744 76.87 57.2K 80,030 D ↗
2024-12-16 Stern Sadie Officer S-Sale D Common Stock 424 76.87 32.6K 70,768 D ↗
2024-12-16 Leach Jacob Steven Officer S-Sale D Common Stock 744 76.87 57.2K 264,171 D ↗
2024-12-16 Heller Bridgette P Director S-Sale D Common Stock 1,000 76.87 76.9K 23,349 D ↗
2024-11-20 Stern Sadie Officer S-Sale D Common Stock 4,259 74.73 318.3K 71,192 D ↗
2024-11-15 Sylvain Jereme M Officer S-Sale D Common Stock 3,500 75.51 264.3K 80,774 D ↗
2024-09-16 Heller Bridgette P Director S-Sale D Common Stock 1,000 70.00 70.0K 24,349 — ↗
2024-09-09 Sylvain Jereme M Officer S-Sale D Common Stock 746 69.15 51.6K 84,274 — ↗
2024-09-09 Stern Sadie Officer S-Sale D Common Stock 426 69.15 29.5K 75,451 — ↗
2024-09-09 Leach Jacob Steven Officer S-Sale D Common Stock 746 69.15 51.6K 264,915 — ↗
2024-08-30 Brown Michael Jon Officer S-Sale D Common Stock 686 70.00 48.0K 65,636 — ↗
2024-07-31 Brown Michael Jon Officer S-Sale D Common Stock 652 69.55 45.3K 66,249 — ↗
2024-06-28 Brown Michael Jon Officer S-Sale D Common Stock 659 114.29 75.3K 66,901 — ↗
2024-06-18 FOLETTA MARK G Director S-Sale D Common Stock 299 117.25 35.1K 56,398 — ↗
2024-06-17 FOLETTA MARK G Director S-Sale D Common Stock 7 115.18 806.26 62,391 — ↗
2024-06-14 Heller Bridgette P Director S-Sale D Common Stock 1,000 113.55 113.6K 25,349 — ↗
2024-06-10 Sylvain Jereme M Officer S-Sale D Common Stock 745 115.05 85.7K 84,948 — ↗
2024-06-10 Stern Sadie Officer S-Sale D Common Stock 427 115.05 49.1K 75,877 — ↗
2024-06-10 Leach Jacob Steven Officer S-Sale D Common Stock 745 115.05 85.7K 265,577 — ↗
2024-05-31 Brown Michael Jon Officer S-Sale D Common Stock 652 119.24 77.7K 67,560 — ↗
2024-05-22 TOPOL ERIC Director A-Award A Common Stock 2,618 0.00 — 2,618 — ↗
2024-05-22 Malady Kyle Director A-Award A Common Stock 2,613 0.00 — 18,142 — ↗
2024-05-22 Heller Bridgette P Director A-Award A Common Stock 2,618 0.00 — 26,349 — ↗
2024-05-22 FOLETTA MARK G Director A-Award A Common Stock 2,973 0.00 — 2,973 — ↗
2024-05-22 Driscoll Rimma Director A-Award A Common Stock 2,632 0.00 — 6,640 — ↗
2024-05-22 Dahut Karen M Director A-Award A Common Stock 2,613 0.00 — 2,613 — ↗
2024-05-22 Collins Richard Alexander Director A-Award A Common Stock 2,632 0.00 — 2,632 — ↗
2024-05-22 AUGUSTINOS NICHOLAS Director A-Award A Common Stock 2,618 0.00 — 2,618 — ↗
2024-05-22 ALTMAN STEVEN R Director A-Award A Common Stock 2,613 0.00 — 2,613 — ↗
2024-05-18 TOPOL ERIC Director G-Gift D Common Stock 2,911 0.00 — 0 — ↗
2024-05-18 KAHN BARBARA Director G-Gift D Common Stock 2,927 0.00 — 0 — ↗
2024-05-18 FOLETTA MARK G Director G-Gift D Common Stock 3,306 0.00 — 0 — ↗
2024-05-18 Dahut Karen M Director G-Gift D Common Stock 2,906 0.00 — 0 — ↗
2024-05-18 Collins Richard Alexander Director G-Gift D Common Stock 2,906 0.00 — 0 — ↗
2024-05-18 AUGUSTINOS NICHOLAS Director G-Gift D Common Stock 3,043 0.00 — 0 — ↗
2024-05-18 ALTMAN STEVEN R Director G-Gift D Common Stock 2,885 0.00 — 0 — ↗
2024-05-15 Dolan Matthew Vincent Officer S-Sale D Common Stock 2,423 126.58 306.7K 40,075 — ↗
2024-04-30 Brown Michael Jon Officer S-Sale D Common Stock 629 126.25 79.4K 68,212 — ↗
2024-04-15 Dolan Matthew Vincent Officer S-Sale D Common Stock 1,990 137.81 274.2K 42,377 — ↗
2024-04-08 SAYER KEVIN R Director / Officer S-Sale D Common Stock 27,272 137.96 3.76M 306,254 — ↗
2024-03-28 Brown Michael Jon Officer S-Sale D Common Stock 2,524 140.02 353.4K 68,782 — ↗
2024-03-25 Stern Sadie Officer S-Sale D Common Stock 4,137 140.00 579.2K 76,304 — ↗
2024-03-15 Dolan Matthew Vincent Officer S-Sale D Common Stock 1,314 130.77 171.8K 45,370 — ↗
2024-03-12 Sylvain Jereme M Officer S-Sale D Common Stock 11,661 134.41 1.57M 85,534 — ↗
2024-03-12 Stern Sadie Officer S-Sale D Common Stock 75 132.71 10.0K 80,441 — ↗
2024-03-12 SAYER KEVIN R Director / Officer S-Sale D Common Stock 14,993 132.43 1.99M 357,395 — ↗
2024-03-12 Leach Jacob Steven Officer G-Gift D Common Stock 7,736 0.00 — 266,177 — ↗
2024-03-12 Lawver Teri L Officer S-Sale D Common Stock 4,764 134.41 640.3K 66,641 — ↗
2024-03-12 Dolan Matthew Vincent Officer S-Sale D Common Stock 6,710 134.41 901.9K 48,570 — ↗
2024-03-12 Brown Michael Jon Officer S-Sale D Common Stock 8,799 134.41 1.18M 71,306 — ↗
2024-03-08 Sylvain Jereme M Officer A-Award A Common Stock 26,053 0.00 — 97,195 — ↗
2024-03-08 Stern Sadie Officer A-Award A Common Stock 21,711 0.00 — 100,762 — ↗
2024-03-08 SAYER KEVIN R Director / Officer A-Award A Common Stock 51,692 0.00 — 414,533 — ↗
2024-03-08 Leach Jacob Steven Officer A-Award A Common Stock 26,053 0.00 — 288,552 — ↗
2024-03-08 Lawver Teri L Officer A-Award A Common Stock 26,053 0.00 — 71,405 — ↗
2024-03-08 Dolan Matthew Vincent Officer A-Award A Common Stock 21,711 0.00 — 55,280 — ↗
2024-03-08 Brown Michael Jon Officer A-Award A Common Stock 21,711 0.00 — 80,105 — ↗
2024-02-20 Sylvain Jereme M Officer S-Sale D Common Stock 3,363 116.73 392.6K 71,142 — ↗
2024-01-16 Sylvain Jereme M Officer S-Sale D Common Stock 2,734 123.63 338.0K 74,505 — ↗
2024-01-16 Stern Sadie Officer S-Sale D Common Stock 2,902 123.63 358.8K 79,051 — ↗
2024-01-16 SAYER KEVIN R Director / Officer S-Sale D Common Stock 37,325 123.63 4.61M 362,841 — ↗
2024-01-16 Leach Jacob Steven Officer S-Sale D Common Stock 3,978 123.63 491.8K 262,499 — ↗
2024-01-16 ALTMAN STEVEN R Director S-Sale D Common Stock 1,108 123.24 136.5K 53,132 — ↗
2024-01-12 Sylvain Jereme M Officer A-Award A Common Stock 7,171 0.00 7.17 77,239 — ↗
2024-01-12 Stern Sadie Officer A-Award A Common Stock 7,620 0.00 7.62 81,953 — ↗
2024-01-12 SAYER KEVIN R Director / Officer A-Award A Common Stock 72,709 0.00 72.71 400,166 — ↗
2024-01-12 Leach Jacob Steven Officer A-Award A Common Stock 9,697 0.00 9.70 266,477 — ↗
2023-12-18 Sylvain Jereme M Officer D-Return D Common Stock 2,932 121.85 357.3K 70,068 — ↗
2023-12-18 Stern Sadie Officer D-Return D Common Stock 1,675 121.85 204.1K 74,333 — ↗
2023-12-18 Regan Barry J. Officer D-Return D Common Stock 1,675 121.85 204.1K 58,469 — ↗
2023-12-18 Leach Jacob Steven Officer D-Return D Common Stock 2,932 121.85 357.3K 256,780 — ↗
2023-12-18 Flynn Paul R Officer D-Return D Common Stock 3,163 121.85 385.4K 48,949 — ↗
2023-12-15 AUGUSTINOS NICHOLAS Director S-Sale D Common Stock 3,976 123.02 489.1K 34,040 — ↗
2023-12-15 ALTMAN STEVEN R Director S-Sale D Common Stock 2,000 122.77 245.5K 54,700 — ↗
2023-12-12 ALTMAN STEVEN R Director S-Sale D Common Stock 3,000 120.00 360.0K 56,700 — ↗
2023-12-11 Stern Sadie Officer S-Sale D Common Stock 392 117.66 46.1K 76,008 — ↗
2023-12-01 Brown Michael Jon Officer S-Sale D Common Stock 900 113.64 102.3K 61,106 — ↗
2023-11-24 Pacelli Steven Robert Director / Officer S-Sale D Common Stock 411 110.80 45.5K 124,775 — ↗
2023-11-22 Stern Sadie Officer S-Sale D Common Stock 1,176 110.00 129.4K 76,400 — ↗
2023-11-19 Stern Sadie Officer D-Return D Common Stock 4,106 104.06 427.3K 77,576 — ↗
2023-11-19 Regan Barry J. Officer D-Return D Common Stock 4,106 104.06 427.3K 60,144 — ↗
2023-11-15 ALTMAN STEVEN R Director S-Sale D Common Stock 1,000 101.26 101.3K 59,700 — ↗
2023-11-09 Naganathan Girish Officer S-Sale D Common Stock 2,725 93.27 254.2K 47,725 — ↗
2023-11-08 Regan Barry J. Officer S-Sale D Common Stock 2,019 95.22 192.2K 64,250 — ↗
2023-10-23 Pacelli Steven Robert Director / Officer S-Sale D Common Stock 411 85.75 35.2K 125,186 — ↗
2023-10-16 ALTMAN STEVEN R Director S-Sale D Common Stock 1,000 77.58 77.6K 60,700 — ↗
2023-09-22 Pacelli Steven Robert Director / Officer S-Sale D Common Stock 411 88.40 36.3K 125,597 — ↗
2023-09-15 ALTMAN STEVEN R Director S-Sale D Common Stock 1,000 101.50 101.5K 61,700 — ↗
2023-09-12 Heller Bridgette P Director S-Sale D Common Stock 600 106.56 63.9K 23,731 — ↗
2023-09-11 Selvaraj Shelly Ramasamy Officer D-Return D Common Stock 2,045 105.25 215.2K 48,453 — ↗
2023-09-01 Dolan Matthew Vincent Officer S-Sale D Common Stock 56 102.32 5.7K 33,569 — ↗
2023-08-24 Driscoll Rimma Director A-Award A Common Stock 4,008 0.00 — 4,008 — ↗
2023-08-23 Pacelli Steven Robert Director / Officer S-Sale D Common Stock 411 107.03 44.0K 126,008 — ↗
2023-08-22 Sylvain Jereme M Officer S-Sale D Common Stock 1,844 104.38 192.5K 72,867 — ↗
2023-08-11 Dahut Karen M Director G-Gift A Common Stock 1,544 0.00 — 12,260 — ↗
2023-08-09 Stern Sadie Officer S-Sale D Common Stock 392 110.71 43.4K 81,682 — ↗
2023-07-24 Pacelli Steven Robert Director / Officer S-Sale D Common Stock 412 130.58 53.8K 126,419 — ↗
2023-07-14 Pacelli Steven Robert Director / Officer S-Sale D Common Stock 5,031 136.00 684.2K 126,831 — ↗
2023-07-10 Stern Sadie Officer S-Sale D Common Stock 392 128.05 50.2K 82,074 — ↗
2023-07-10 Regan Barry J. Officer S-Sale D Common Stock 1,989 128.05 254.7K 66,269 — ↗
2023-06-23 Pacelli Steven Robert Director / Officer S-Sale D Common Stock 412 125.92 51.9K 131,862 — ↗
2023-06-15 Selvaraj Shelly Ramasamy Officer S-Sale D Common Stock 2,115 130.00 275.0K 50,390 — ↗
2023-06-09 Stern Sadie Officer S-Sale D Common Stock 393 121.31 47.7K 82,466 — ↗
2023-05-23 Pacelli Steven Robert Director / Officer S-Sale D Common Stock 412 118.65 48.9K 132,274 — ↗
2023-05-22 Sylvain Jereme M Officer S-Sale D Common Stock 2,400 117.58 282.2K 74,711 — ↗
2023-05-18 TOPOL ERIC Director G-Gift A Common Stock 3,952 0.00 — 375,016 — ↗
2023-05-18 SKYLER JAY S Director G-Gift A Common Stock 3,876 0.00 — 63,348 — ↗
2023-05-18 Malady Kyle Director A-Award A Common Stock 2,885 0.00 2.89 15,529 — ↗
2023-05-18 KAHN BARBARA Director G-Gift A Common Stock 3,976 0.00 — 19,648 — ↗
2023-05-18 Heller Bridgette P Director A-Award A Common Stock 2,911 0.00 2.91 24,331 — ↗
2023-05-18 FOLETTA MARK G Director A-Award A Common Stock 3,306 0.00 3.31 7,794 — ↗
2023-05-18 Dahut Karen M Director G-Gift A Common Stock 3,948 0.00 — 10,716 — ↗
2023-05-18 Collins Richard Alexander Director G-Gift D Common Stock 3,948 0.00 — 2,906 — ↗
2023-05-18 AUGUSTINOS NICHOLAS Director G-Gift A Common Stock 3,976 0.00 — 38,016 — ↗
2023-05-18 ALTMAN STEVEN R Director A-Award A Common Stock 2,885 0.00 2.89 6,801 — ↗
2023-05-09 Stern Sadie Officer S-Sale D Common Stock 393 120.19 47.2K 82,859 — ↗
2023-04-27 Pacelli Steven Robert Director / Officer S-Sale D Common Stock 5,031 126.00 633.9K 132,686 — ↗
2023-04-24 Pacelli Steven Robert Director / Officer S-Sale D Common Stock 412 124.68 51.4K 137,717 — ↗
2023-04-20 Selvaraj Shelly Ramasamy Officer S-Sale D Common Stock 2,007 125.00 250.9K 52,505 — ↗
2023-04-20 Regan Barry J. Officer S-Sale D Common Stock 2,214 124.50 275.6K 68,258 — ↗
2023-04-20 Leach Jacob Steven Officer S-Sale D Common Stock 30,764 125.00 3.85M 259,613 — ↗
2023-04-17 Flynn Paul R Officer S-Sale D Common Stock 2,781 120.00 333.7K 52,112 — ↗
2023-04-10 Stern Sadie Officer S-Sale D Common Stock 393 112.35 44.2K 83,252 — ↗
2023-04-03 SAYER KEVIN R Director / Officer S-Sale D Common Stock 3,599 115.70 416.4K 327,457 — ↗
2023-04-03 Brown Michael Jon Officer S-Sale D Common Stock 253 116.03 29.4K 61,870 — ↗
2023-03-23 Pacelli Steven Robert Director / Officer S-Sale D Common Stock 5,442 116.40 633.4K 138,129 — ↗
2023-03-16 Dolan Matthew Vincent Officer S-Sale D Common Stock 2,303 115.00 264.8K 33,569 — ↗
2023-03-14 Stern Sadie Officer S-Sale D Common Stock 393 111.86 44.0K 83,645 — ↗
2023-03-13 Regan Barry J. Officer S-Sale D Common Stock 2,010 106.27 213.6K 70,472 — ↗
2023-03-13 Flynn Paul R Officer S-Sale D Common Stock 2,782 106.27 295.6K 54,893 — ↗

Executive team

Top executives
EBIT / Employee
89.4K
Shares Outstanding
385.87M

Executive compensation

Executive compensation (annual)
# Year ⇅ Executive ⇅ Salary ⇅ Bonus Stock award ⇅ Option award Incentive Other Total ⇅ % Stock-
based ⇅		 Filing
1 2025 Kevin Sayer Executive Chairman 1.21M — 13.85M — 1.14M 70.9K 16.28M 85.08% ↗
2 2025 Jacob Leach President & Chief Executive Officer 769.0K — 5.94M — 1.16M 116.2K 7.99M 74.33% ↗
3 2025 Jereme Sylvain EVP, Chief Financial Officer 646.6K — 5.94M — 465.6K 29.6K 7.08M 83.87% ↗
4 2025 Jon Coleman EVP, Chief Commercial Officer 491.5K — 5.83M — 353.9K 68.9K 6.75M 86.45% ↗
5 2025 Michael Brown EVP, Chief Legal Officer 631.6K — 5.24M — 454.8K 15.0K 6.34M 82.64% ↗
6 2025 Sadie Stern EVP, Chief Human Resources Officer 571.2K — 5.24M — 411.3K 28.2K 6.25M 83.84% ↗
7 2024 Kevin Sayer Executive Chairman 1.16M — 14.54M — — 135.4K 15.83M 91.83% ↗
8 2024 Kevin R. Sayer Chairperson, President & Chief Executive Officer 1.16M — 14.54M — — 135.4K 15.83M 91.83% ↗
9 2024 Teri L. Lawver Former EVP, Chief Commercial Officer 607.1K 100.0K 5.23M — — 516.6K 6.45M 81.04% ↗
10 2024 Jacob Leach President & Chief Executive Officer 682.5K — 5.23M — — 10.6K 5.92M 88.30% ↗
11 2024 Jacob S. Leach EVP, Chief Operating Officer 682.5K — 5.23M — — 10.6K 5.92M 88.30% ↗
12 2024 Jereme Sylvain EVP, Chief Financial Officer 609.3K — 5.23M — — 12.6K 5.85M 89.37% ↗
13 2024 Jereme M. Sylvain EVP, Chief Financial Officer 609.3K — 5.23M — — 12.6K 5.85M 89.37% ↗
14 2024 Michael Brown EVP, Chief Legal Officer 596.9K — 4.36M — — 10.4K 4.96M 87.77% ↗
15 2024 Michael J. Brown EVP, Chief Legal Officer 596.9K — 4.36M — — 10.4K 4.96M 87.77% ↗
16 2024 Sadie M. Stern EVP, Chief Human Resources Officer 539.8K — 4.36M — — 11.0K 4.91M 88.78% ↗
17 2024 Sadie Stern EVP, Chief Human Resources Officer 539.8K — 4.36M — — 11.0K 4.91M 88.78% ↗
18 2023 Kevin R. Sayer Chairperson, President & Chief Executive Officer 1.09M — 12.49M — 1.99M 143.5K 15.71M 79.47% ↗
19 2023 Kevin Sayer Executive Chairman 1.09M — 12.49M — 1.99M 143.5K 15.71M 79.47% ↗
20 2023 Teri L. Lawver EVP, Chief Commercial Officer 528.2K 100.0K 5.11M — 554.6K 230.9K 6.53M 78.34% ↗
21 2023 Teri L. Lawver Former EVP, Chief Commercial Officer 528.2K 100.0K 5.11M — 554.6K 230.9K 6.53M 78.34% ↗
22 2023 Jacob S. Leach EVP, Chief Operating Officer 625.1K — 3.65M — 656.3K 8.3K 4.94M 73.88% ↗
23 2023 Jacob Leach President & Chief Executive Officer 625.1K — 3.65M — 656.3K 8.3K 4.94M 73.88% ↗
24 2023 Michael Brown EVP, Chief Legal Officer 546.6K — 3.13M — 660.1K 8.9K 4.34M 72.01% ↗
25 2023 Michael J. Brown EVP, Chief Legal Officer 546.6K — 3.13M — 660.1K 8.9K 4.34M 72.01% ↗
26 2023 Jereme Sylvain EVP, Chief Financial Officer 533.6K — 3.13M — 560.3K 33.8K 4.25M 73.50% ↗
27 2023 Jereme M. Sylvain EVP, Chief Financial Officer 533.6K — 3.13M — 560.3K 33.8K 4.25M 73.50% ↗
28 2022 Kevin R. Sayer Chairperson, President & Chief Executive Officer 953.4K — 13.21M — 1.25M 18.1K 15.44M 85.60% ↗
29 2022 Michael J. Brown EVP, Chief Legal Officer 491.9K — 4.82M — 402.1K 27.4K 5.75M 83.96% ↗
30 2022 Jacob S. Leach EVP, Chief Operating Officer 534.7K — 3.43M — 437.2K 22.2K 4.43M 77.55% ↗
31 2022 Girish Naganathan EVP, Chief Technology Officer 120.5K 200.0K 3.63M — 98.5K 4.8K 4.05M 89.54% ↗
32 2022 Jereme M. Sylvain EVP, Chief Financial Officer 426.3K — 2.70M — 365.9K 48.9K 3.54M 76.23% ↗
33 2021 Kevin R. Sayer Chairperson, President & Chief Executive Officer 900.0K — 9.60M — 1.47M 14.8K 11.99M 80.07% ↗
34 2021 Kevin R. Sayer Chairman, President & Chief Executive Officer 900.0K — 9.60M — 1.47M 14.8K 11.99M 80.07% ↗
35 2021 Jacob S. Leach EVP, Chief Technology Officer 450.0K — 4.79M — 442.1K 23.8K 5.71M 83.95% ↗
36 2021 Jacob S. Leach EVP, Chief Operating Officer 450.0K — 4.79M — 442.1K 23.8K 5.71M 83.95% ↗
37 2021 Chad M. Patterson EVP, Global Marketing 373.8K — 4.10M — 367.2K 29.5K 4.88M 84.20% ↗
38 2021 Paul Flynn EVP, Global Revenue 374.0K — 4.10M — 367.4K 20.1K 4.87M 84.35% ↗
39 2021 Jereme M. Sylvain EVP, Chief Financial Officer 379.5K — 3.96M — 372.9K 30.8K 4.74M 83.47% ↗
40 2021 Quentin S. Blackford Former Chief Operating Officer and Former Chief Financial Officer 425.8K — 4.18M — — 18.9K 4.62M 90.38% ↗
41 2020 Kevin R. Sayer Chairperson, President & Chief Executive Officer 800.0K — 11.18M — 1.71M 115.8K 13.80M 80.98% ↗
42 2020 Kevin R. Sayer Chairman, President & Chief Executive Officer 800.0K — 11.18M — 1.71M 115.8K 13.80M 80.98% ↗
43 2020 Jeffrey C. Moy EVP, Operations 382.2K — 6.55M — 490.4K 51.8K 7.48M 87.64% ↗
44 2020 Richard B. Doubleday EVP, Chief Commercial Officer 464.8K — 4.72M — 596.1K 75.9K 5.85M 80.58% ↗
45 2020 Quentin S. Blackford Chief Operating Officer and Chief Financial Officer 562.8K — 3.65M — 830.1K 88.6K 5.13M 71.11% ↗
46 2020 Quentin S. Blackford Former Chief Operating Officer and Former Chief Financial Officer 562.8K — 3.65M — 830.1K 88.6K 5.13M 71.11% ↗
47 2020 Jacob S. Leach EVP, Chief Technology Officer 409.4K — 3.37M — 525.1K 69.6K 4.37M 77.03% ↗
48 2020 Jacob S. Leach EVP, Chief Operating Officer 409.4K — 3.37M — 525.1K 69.6K 4.37M 77.03% ↗
49 2019 Kevin R. Sayer Chairman, President and Chief Executive Officer 691.2K — 8.19M — 1.38M 19.4K 10.28M 79.64% ↗
50 2019 Kevin R. Sayer Chairman, President & Chief Executive Officer 691.2K — 8.19M — 1.38M 19.4K 10.28M 79.64% ↗
51 2019 Quentin S. Blackford Former Chief Operating Officer and Former Chief Financial Officer 516.8K — 2.64M — 620.1K 29.8K 3.81M 69.35% ↗
52 2019 Quentin S. Blackford Chief Operating Officer and Chief Financial Officer 516.8K — 2.64M — 620.1K 29.8K 3.81M 69.35% ↗
53 2019 Richard B. Doubleday EVP, Chief Commercial Officer 414.7K — 2.34M — 497.7K 17.7K 3.27M 71.59% ↗
54 2019 Andrew K. Balo EVP, Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development 384.3K 7.5K 2.15M — 461.2K 23.0K 3.02M 71.02% ↗
55 2019 Steven R. Pacelli EVP, Strategy and Corporate Development 384.3K 5.0K 2.15M — 461.2K 23.2K 3.02M 71.08% ↗
56 2018 Kevin Sayer Chairman, President and Chief Executive Officer 600.9K — 7.67M — 1.26M 22.4K 9.55M 80.27% ↗
57 2018 Kevin R. Sayer Chairman, President & Chief Executive Officer 600.9K — 7.67M — 1.26M 22.4K 9.55M 80.27% ↗
58 2018 Quentin Blackford EVP, Chief Financial Officer 463.5K — 2.32M — 584.0K 26.3K 3.39M 68.34% ↗
59 2018 Quentin S. Blackford Chief Operating Officer and Chief Financial Officer 463.5K — 2.32M — 584.0K 26.3K 3.39M 68.34% ↗
60 2018 Richard Doubleday EVP, Chief Commercial Officer 383.7K — 2.32M — 483.5K 22.4K 3.21M 72.26% ↗
61 2018 Richard B. Doubleday EVP, Chief Commercial Officer 383.7K — 2.32M — 483.5K 22.4K 3.21M 72.26% ↗
62 2018 Andrew Balo EVP, Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development 366.0K 7.5K 2.32M — 461.1K 22.3K 3.17M 73.01% ↗
63 2018 Steven Pacelli EVP, Strategy and Corporate Development 366.0K 5.0K 2.32M — 461.1K 22.4K 3.17M 73.06% ↗
64 2017 Kevin Sayer Chief Executive Officer and President 546.3K — 6.36M — 996.9K 22.4K 7.92M 80.24% ↗
65 2017 Kevin Sayer Chairman, President and Chief Executive Officer 546.3K — 6.36M — 996.9K 22.4K 7.92M 80.24% ↗
66 2017 Quentin S. Blackford Chief Financial Officer 150.0K 150.0K 4.44M — 369.6K 3.9K 5.12M 86.83% ↗
67 2017 Quentin Blackford EVP, Chief Financial Officer 150.0K 150.0K 4.44M — 369.6K 3.9K 5.12M 86.83% ↗
68 2017 Terrance H. Gregg Executive Chairman 240.0K — 2.42M — 438.0K 15.7K 3.11M 77.70% ↗
69 2017 Andrew Balo EVP, Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development 355.3K — 2.25M — 389.1K 22.3K 3.02M 74.59% ↗
70 2017 Richard Doubleday EVP, Chief Commercial Officer 355.3K — 2.15M — 389.1K 22.4K 2.92M 73.73% ↗
71 2017 Steven Pacelli EVP, Strategy and Corporate Development 355.3K — 2.15M — 389.1K 22.4K 2.92M 73.73% ↗
72 2017 Donald M. Abbey EVP, Quality and Regulatory Affairs 355.3K — 2.15M — 389.1K 22.4K 2.92M 73.73% ↗
73 2017 Steven R. Pacelli EVP-Strategy and Corporate Development 355.3K — 2.15M — 389.1K 22.4K 2.92M 73.73% ↗
74 2017 Kevin Sun Previous Interim Chief Financial Officer 248.2K — 753.4K — 144.9K 20.1K 1.17M 64.58% ↗
75 2017 Jess Roper Previous Chief Financial Officer 71.3K — — — — 322.9K 394.2K 0.00% ↗
76 2016 Kevin Sayer Chief Executive Officer and President 475.0K — 5.95M — 581.1K 23.9K 7.03M 84.63% ↗
77 2016 Kevin Sayer Chairman, President and Chief Executive Officer 475.0K — 5.95M — 581.1K 23.9K 7.03M 84.63% ↗
78 2016 Donald M. Abbey EVP, Quality 199.6K — 3.55M — 166.4K 14.7K 3.93M 90.31% ↗
79 2016 Donald M. Abbey EVP, Quality and Regulatory Affairs 199.6K — 3.55M — 166.4K 14.7K 3.93M 90.31% ↗
80 2016 Richard Doubleday EVP, Chief Commercial Officer 340.0K — 2.51M — 249.6K 23.8K 3.13M 80.37% ↗
81 2016 Steven Pacelli EVP, Strategy and Corporate Development 340.0K — 2.51M — 249.6K 23.8K 3.13M 80.37% ↗
82 2016 Steven R. Pacelli EVP-Strategy and Corporate Development 340.0K — 2.51M — 249.6K 23.8K 3.13M 80.37% ↗
83 2016 Jess Roper Senior Vice President and Chief Financial Officer 285.0K — 1.98M — 139.5K 17.1K 2.42M 81.79% ↗
84 2016 Jess Roper Previous Chief Financial Officer 285.0K — 1.98M — 139.5K 17.1K 2.42M 81.79% ↗
85 2015 Kevin Sayer Chief Executive Officer and President 400.0K — 5.36M — 815.6K 23.0K 6.60M 81.24% ↗
86 2015 Richard Doubleday EVP, Chief Commercial Officer 310.0K — 2.83M — 379.3K 22.9K 3.54M 79.90% ↗
87 2015 Andrew Balo EVP, Clinical, Regulatory and Quality 310.0K — 2.83M — 379.3K 22.5K 3.54M 79.91% ↗
88 2015 Steven R. Pacelli EVP-Strategy and Corporate Development 310.0K — 2.68M — 379.3K 22.9K 3.39M 79.02% ↗
89 2015 Jess Roper Previous Chief Financial Officer 260.0K — 2.38M — 212.1K 16.5K 2.87M 82.99% ↗
90 2015 Jess Roper Senior Vice President and Chief Financial Officer 260.0K — 2.38M — 212.1K 16.5K 2.87M 82.99% ↗
91 2014 Terrance H. Gregg Executive Chairman 420.0K — 8.67M — 1.01M 33.0K 10.15M 85.43% ↗
92 2014 Kevin Sayer Chief Executive Officer and President 325.0K — 7.11M — 624.0K 22.0K 8.08M 87.99% ↗
93 2014 Kevin Sayer Chief Executive Officer and President 325.0K — 7.11M — 624.0K 22.0K 8.08M 87.99% ↗
94 2014 Jorge Valdes EVP-Chief Technical Officer 296.4K — 3.37M — 426.8K 21.8K 4.11M 81.88% ↗
95 2014 Steven R. Pacelli EVP-Strategy and Corporate Development 296.4K — 3.37M — 426.8K 21.8K 4.11M 81.88% ↗
96 2014 Steven R. Pacelli EVP-Strategy and Corporate Development 296.4K — 3.37M — 426.8K 21.8K 4.11M 81.88% ↗
97 2014 Jess Roper Senior Vice President and Chief Financial Officer 248.9K — 1.42M — 191.1K 15.7K 1.88M 75.74% ↗
98 2014 Jess Roper Senior Vice President and Chief Financial Officer 248.9K — 1.42M — 191.1K 15.7K 1.88M 75.74% ↗
99 2013 Terrance H. Gregg Executive Chairman 420.0K — 2.85M — 1.02M 13.2K 4.30M 66.24% ↗
100 2013 Terrance H. Gregg Chief Executive Officer 420.0K — 2.85M — 1.02M 13.2K 4.30M 66.24% ↗
101 2013 Kevin Sayer Chief Executive Officer and President 325.0K — 2.34M — 629.7K 18.5K 3.31M 70.59% ↗
102 2013 Kevin Sayer Chief Executive Officer and President 325.0K — 2.34M — 629.7K 18.5K 3.31M 70.59% ↗
103 2013 Kevin Sayer President and Chief Operating Officer 325.0K — 2.34M — 629.7K 18.5K 3.31M 70.59% ↗
104 2013 Steven R. Pacelli EVP-Strategy and Corporate Development 284.9K — 1.12M — 414.1K 18.5K 1.83M 60.85% ↗
105 2013 Jorge Valdes Chief Technical Officer 284.9K — 1.12M — 414.1K 18.5K 1.83M 60.85% ↗
106 2013 Steven R. Pacelli EVP- Strategy and Corporate Development 284.9K — 1.12M — 414.1K 18.5K 1.83M 60.85% ↗
107 2013 Steven R. Pacelli EVP-Strategy and Corporate Development 284.9K — 1.12M — 414.1K 18.5K 1.83M 60.85% ↗
108 2013 Jorge Valdes EVP-Chief Technical Officer 284.9K — 1.12M — 414.1K 18.5K 1.83M 60.85% ↗
109 2013 Jess Roper Vice President and Chief Financial Officer 237.0K — 467.1K — 183.7K 13.1K 900.8K 51.85% ↗
110 2013 Jess Roper Senior Vice President and Chief Financial Officer 237.0K — 467.1K — 183.7K 13.1K 900.8K 51.85% ↗
111 2013 Jess Roper Senior Vice President and Chief Financial Officer 237.0K — 467.1K — 183.7K 13.1K 900.8K 51.85% ↗
112 2012 Terrance H. Gregg Chief Executive Officer 420.0K — 1.89M — 466.2K 12.3K 2.79M 67.80% ↗
113 2012 Kevin Sayer Chief Executive Officer and President 325.0K — 1.29M — 324.7K 16.9K 1.96M 65.99% ↗
114 2012 Kevin Sayer President and Chief Operating Officer 325.0K — 1.29M — 324.7K 16.9K 1.96M 65.99% ↗
115 2012 Steven R. Pacelli EVP- Strategy and Corporate Development 279.5K — 741.2K — 232.6K 17.1K 1.27M 58.34% ↗
116 2012 Steven R. Pacelli EVP-Strategy and Corporate Development 279.5K — 741.2K — 232.6K 17.1K 1.27M 58.34% ↗
117 2012 Jorge Valdes EVP-Chief Technical Officer 279.5K — 741.2K — 232.6K 17.1K 1.27M 58.34% ↗
118 2012 Jorge Valdes Chief Technical Officer 279.5K — 741.2K — 232.6K 17.1K 1.27M 58.34% ↗
119 2012 Jess Roper Vice President and Chief Financial Officer 230.0K — 265.2K — 89.4K 12.0K 596.6K 44.45% ↗
120 2012 Jess Roper Senior Vice President and Chief Financial Officer 230.0K — 265.2K — 89.4K 12.0K 596.6K 44.45% ↗
121 2011 Terrance H. Gregg Chief Executive Officer 420.0K — 2.63M — 420.0K 12.3K 3.49M 75.55% ↗
122 2011 Kevin Sayer President and Chief Operating Officer 175.0K — 1.50M — 156.6K 215.1K 2.05M 73.29% ↗
123 2011 Kevin Sayer President and Chief Operating Officer 175.0K — 1.50M — 156.6K 215.1K 2.05M 73.29% ↗
124 2011 Jorge Valdes Chief Technical Officer 270.0K — 1.48M — 202.5K 17.1K 1.97M 75.17% ↗
125 2011 Steven R. Pacelli EVP- Strategy and Corporate Development 270.0K — 1.48M — 202.5K 17.1K 1.97M 75.17% ↗
126 2011 Steven R. Pacelli Chief Operating Officer 270.0K — 1.48M — 202.5K 17.1K 1.97M 75.17% ↗
127 2011 Jess Roper Vice President and Chief Financial 210.0K — 369.2K — 73.5K 12.0K 664.7K 55.55% ↗
128 2011 Jess Roper Vice President and Chief Financial Officer 210.0K — 369.2K — 73.5K 12.0K 664.7K 55.55% ↗
129 2010 Terrance H. Gregg Chief Executive Officer 420.0K 46.2K 1.43M — 336.0K 11.3K 2.25M 63.79% ↗
130 2010 Terrance H. Gregg President and Chief Executive Officer 420.0K 46.2K 1.43M — 336.0K 11.3K 2.25M 63.79% ↗
131 2010 Steven R. Pacelli EVP- Strategy and Corporate Development 266.4K — — 500.9K 245.7K 15.7K 1.03M 48.69% ↗
132 2010 Steven R. Pacelli Chief Operating Officer 266.4K — — 500.9K 245.7K 15.7K 1.03M 48.69% ↗
133 2010 Jorge Valdes Chief Technical Officer 264.3K — — 500.9K 246.0K 15.7K 1.03M 48.78% ↗
134 2010 Andrew Balo Sr. V.P., Clinical Regulatory Affairs 261.0K — — 500.9K 135.7K 15.7K 913.3K 54.84% ↗
135 2010 Jess Roper Vice President and Chief Financial 205.0K — — 250.5K 80.0K 6.4K 541.8K 46.22% ↗
136 2010 Jess Roper Vice President and Chief Financial Officer 205.0K — — 250.5K 80.0K 6.4K 541.8K 46.22% ↗
137 2009 Terrance H. Gregg Chief Executive Officer 420.0K — — — 231.0K 3.6K 654.6K 0.00% ↗
138 2009 Terrance H. Gregg President and Chief Executive Officer 420.0K — — — 231.0K 3.6K 654.6K 0.00% ↗
139 2009 Richard Doubleday Vice President of Sales 110.0K — — 365.7K 42.4K 10.5K 528.5K 69.19% ↗
140 2009 John Lister Vice President of Legal Affairs 185.1K — — 138.9K 52.3K 18.2K 394.4K 35.21% ↗
141 2009 Steven R. Pacelli Chief Operating Officer 260.7K — — — 114.7K 11.5K 386.9K 0.00% ↗
142 2009 Steven R. Pacelli Chief Administrative Officer 260.7K — — — 114.7K 11.5K 386.9K 0.00% ↗
143 2009 Andrew Balo Sr. V.P., Clinical Regulatory Affairs 255.0K — — — 98.2K 18.4K 371.6K 0.00% ↗
144 2009 Andrew Balo Sr. V.P., Clinical Regulatory Affairs 255.0K — — — 98.2K 18.4K 371.6K 0.00% ↗
145 2009 Jorge Valdes Chief Technical Officer 254.4K — — — 97.9K 18.4K 370.7K 0.00% ↗
146 2009 Jorge Valdes Chief Technical Officer 254.4K — — — 97.9K 18.4K 370.7K 0.00% ↗
147 2009 Jess Roper Vice President and Chief Financial Officer 200.0K — — — 55.0K 6.1K 261.1K 0.00% ↗
148 2009 Jess Roper Vice President and Chief Financial 200.0K — — — 55.0K 6.1K 261.1K 0.00% ↗
149 2008 Terrance H. Gregg President and Chief Executive Officer 423.2K — 825.2K 2.24M — 4.0K 3.49M 87.76% ↗
150 2008 Jorge Valdes Chief Technical Officer 256.2K — — 638.1K — 18.2K 912.5K 69.93% ↗
151 2008 Andrew Balo Sr. V.P., Clinical Regulatory Affairs 255.9K — — 638.1K — 18.2K 912.2K 69.95% ↗
152 2008 Steven R. Pacelli Chief Administrative Officer 250.6K — — 638.1K — 11.5K 900.2K 70.88% ↗
153 2008 Steven R. Pacelli Chief Operating Officer 250.6K — — 638.1K — 11.5K 900.2K 70.88% ↗
154 2008 Jess Roper Vice President and Chief Financial Officer 192.2K — — 472.0K — 5.1K 669.3K 70.53% ↗
155 2008 Jorge Valdes Sr. Vice President of Operations 256.2K — — 388.8K — 18.2K 663.2K 58.63% ↗
156 2008 John Lister Vice President of Legal Affairs 160.2K 76.5K — 281.0K — 16.5K 534.2K 52.60% ↗
157 2008 Andrew Balo Sr. V.P., Clinical Regulatory Affairs Quality Assurance 255.9K — — 241.9K — 18.2K 515.9K 46.88% ↗
158 2008 Richard Doubleday Vice President of Sales — — — — — — — — ↗
159 2007 Terrance H. Gregg President and Chief Executive Officer 215.4K 119.5K — 3.53M — 811.00 3.87M 91.32% ↗
160 2007 Steven R. Pacelli Chief Administrative Officer 226.1K 46.4K — 631.5K — 4.3K 908.3K 69.53% ↗
161 2007 Andrew P. Rasdal President and Chief Executive Officer 452.3K — — 433.1K — 11.7K 897.1K 48.27% ↗
162 2007 Steve Pacelli Sr. Vice President of Corporate Affairs 226.1K 46.4K — 449.5K — 4.3K 726.3K 61.90% ↗
163 2007 Jorge Valdes Sr. Vice President of Operations 235.3K 48.0K — 338.9K — 12.1K 634.3K 53.44% ↗
164 2007 Rodney Kellogg Vice President of Sales 215.9K 68.6K — 292.0K — 12.0K 588.6K 49.62% ↗
165 2007 Andrew Balo Sr. V.P., Clinical Regulatory Affairs Quality Assurance 236.6K 47.6K — 162.4K — 12.1K 458.6K 35.41% ↗
166 2007 Steven J. Kemper Chief Financial Officer 245.9K — — 170.7K — 11.8K 428.4K 39.85% ↗
167 2007 Jess Roper Vice President and Chief Financial Officer 136.4K 35.0K 10.9K 121.9K — 4.0K 308.1K 43.10% ↗
168 2007 John Lister Vice President of Legal Affairs — — — — — — — — ↗
169 2007 Richard Doubleday Vice President of Sales — — — — — — — — ↗
170 2006 Andrew P. Rasdal President and Chief Executive Officer 398.8K — — 605.9K — 11.8K 1.02M 59.61% ↗
171 2006 Andrew P. Rasdal President and Chief Executive Officer 398.8K — — 605.9K — 11.8K 1.02M 59.61% ↗
172 2006 Rodney Kellogg Vice President of Sales 210.0K — — 402.2K — 11.7K 623.9K 64.46% ↗
173 2006 Rodney Kellogg Vice President of Sales 210.0K — — 402.2K — 11.7K 623.9K 64.46% ↗
174 2006 Jorge Valde s Vice President of Engineering 210.6K — — 374.0K — 11.7K 596.4K 62.71% ↗
175 2006 Jorge Valdes Sr. Vice President of Operations 210.6K — — 374.0K — 11.7K 596.4K 62.71% ↗
176 2006 Mark Brister Vice President, Advanced Development Teams 235.0K — — 220.2K — 11.7K 466.9K 47.16% ↗
177 2006 Andrew Balo Sr. V.P., Clinical Regulatory Affairs Quality Assurance 230.0K — — 195.5K — 7.2K 432.7K 45.19% ↗
178 2006 Steve Pacelli Sr. Vice President of Corporate Affairs 145.9K 50.0K — 230.7K — 3.0K 429.6K 53.70% ↗
179 2006 Steven R. Pacelli Chief Administrative Officer 145.9K 50.0K — 230.7K — 3.0K 429.6K 53.70% ↗
180 2006 Steven J. Kemper Chief Financial Officer 225.0K 50.0K — 138.8K — 11.8K 425.6K 32.62% ↗
181 2006 Steven J. Kemper Chief Financial Officer 225.0K 50.0K — 138.8K — 11.8K 425.6K 32.62% ↗
182 2006 Jess Roper Vice President and Chief Financial Officer 127.2K 10.0K — 31.1K — 3.9K 172.3K 18.08% ↗
183 2006 Terrance H. Gregg President and Chief Executive Officer — — — — — — — — ↗
184 2005 Andrew P. Rasdal President and Chief Executive 343.5K 76.4K — — — — 419.9K 0.00% ↗
185 2005 Andrew K. Balo Vice President of Clinical and 210.5K 51.7K — — — — 262.1K 0.00% ↗
186 2005 Mark Brister Vice President, Advanced 207.2K 50.9K — — — — 258.1K 0.00% ↗
187 2005 Steven J. Kemper Chief Financial Officer 221.2K — — — — — 221.2K 0.00% ↗
188 2005 James H. Brauker, Ph. D. Vice President of Research and 202.7K — — — — — 202.7K 0.00% ↗
189 2004 Andrew P. Rasdal President and Chief Executive 323.4K — — — — — 323.4K 0.00% ↗
190 2004 Steven J. Kemper Chief Financial Officer 212.6K — — — — — 212.6K 0.00% ↗
191 2004 Andrew K. Balo Vice President of Clinical and 202.3K — — — — — 202.3K 0.00% ↗
192 2004 James H. Brauker, Ph. D. Vice President of Research and 202.3K — — — — — 202.3K 0.00% ↗
193 2004 Mark Brister Vice President, Advanced 195.3K — — — — — 195.3K 0.00% ↗
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-04-15 DEFA14A ↗
2026-04-15 DEF 14A ↗
2025-05-02 DEFA14A ↗
2025-03-27 DEFA14A ↗
2025-03-27 DEF 14A ↗

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-11 4 ↗
2026-05-11 4 ↗
2026-05-11 4 ↗
2026-05-11 4 ↗
2026-04-30 8-K ↗
2026-04-30 10-Q ↗
2026-04-29 SC 13G ↗
2026-04-29 SC 13G ↗
2026-04-16 4 ↗
2026-04-15 DEFA14A ↗

Executive team

NameTitleCompensationGender
Kevin Ronald Sayer Executive Chairman of the Board 2M male
Jacob Steven Leach President, CEO & Director 2M male
Jereme Sylvain Executive Vice President, Chief Financial Officer & Chief Accounting Officer 1M male
Michael Brown Executive Vice President & Chief Legal Officer 1M male
Jon Coleman Executive Vice President & Chief Commercial Officer 1M male
Sadie Stern Executive Vice President & Chief Human Resources Officer 1M female
Donald Abbey Executive Vice President of Global Business Services, Regulatory, Medical & Clinical Affairs 766.8K male
Girish Naganathan Executive Vice President & Chief Technology Officer 423.9K male
Sean Christensen Vice President of Finance and Investor Relations — male
Keri Leone Senior Director of Global Medical Science & Education — —
Matthew Dolan Executive Vice President of Strategy & Corporate Development — male
Christine Pospisil Director of Medical Science & Education — —
ESG Rating
B-
MEDICAL - DEVICES
2016
E (Environmental)
51.0 / 62.5
Company / Sector avg.
S (Social)
48.1 / 68.9
Company / Sector avg.
G (Governance)
58.3 / 64.8
Company / Sector avg.
ESG Total
52.4 / 65.4
Company / Sector avg.
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
Transaction Date Disclosed Senator State Owner Type Amount Link
2026-01-26 2026-02-15 John Boozman AR Joint Purchase $1,001 - $15,000 ↗
2020-03-17 2020-04-16 Tina Smith MN Spouse Sale (Partial) $250,001 - $500,000 ↗
House Trading Activity
Transaction Date Disclosed Representative District Owner Type Amount Link
2025-09-29 2025-10-03 Ro Khanna CA17 — Sale $1,001 - $15,000 ↗
2025-09-22 2025-10-13 Michael McCaul TX10 Spouse Purchase $1,001 - $15,000 ↗
2025-06-16 2025-07-09 Michael McCaul TX10 Spouse Sale $15,001 - $50,000 ↗
2025-06-02 2025-07-09 Michael McCaul TX10 Spouse Purchase $15,001 - $50,000 ↗
2025-05-15 2025-06-10 Rob Bresnahan PA08 — Purchase $1,001 - $15,000 ↗
2025-04-08 2025-04-29 Rob Bresnahan PA08 — Sale $1,001 - $15,000 ↗
2025-04-08 2025-05-15 Michael McCaul TX10 Spouse Purchase $50,001 - $100,000 ↗
2025-04-07 2025-05-09 Jefferson Shreve IN06 — Sale $15,001 - $50,000 ↗
2025-03-13 2025-04-18 Michael McCaul TX10 Spouse Purchase $15,001 - $50,000 ↗
2025-02-25 2025-03-28 Rob Bresnahan PA08 — Purchase $1,001 - $15,000 ↗
2024-12-31 2025-01-15 Kevin Hern OK01 Joint Sale (Full) $50,001 - $100,000 ↗
2024-09-09 2024-10-08 Ro Khanna CA17 — Purchase $1,001 - $15,000 ↗
2023-10-31 2023-11-08 Ro Khanna CA17 Spouse Purchase $1,001 - $15,000 ↗
2023-10-10 2023-11-08 Ro Khanna CA17 Spouse Sale $1,001 - $15,000 ↗
2023-10-02 2023-11-08 Ro Khanna CA17 — Purchase $1,001 - $15,000 ↗
2023-09-12 2023-10-15 Josh Gottheimer NJ05 Joint Sale $1,001 - $15,000 ↗
2023-09-06 2023-10-06 Ro Khanna CA17 Spouse Sale $1,001 - $15,000 ↗
2023-08-29 2023-09-06 Ro Khanna CA17 — Sale $1,001 - $15,000 ↗
2023-05-23 2023-06-12 Ro Khanna CA17 — Purchase $1,001 - $15,000 ↗
2022-12-05 2023-01-03 Ro Khanna CA17 — Sale $1,001 - $15,000 ↗
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Devices